Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-30

Clinical Trial Update: TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk [NA]

View source ↗

Summary

A completed primary prevention trial (TRIGR) evaluating type 1 diabetes prevention in at-risk children; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Helsinki | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2021-07-30